Clark Estates Inc’s Vir Biotechnology VIR Stock Holding History

Clark Estates Inc’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-180,000	Closed	-$4.56M	–	103
2022 Q4	$4.56M	Hold	180,000	–	–	0.95%	29
2022 Q3	$3.47M	Hold	180,000	–	–	0.77%	40
2022 Q2	$4.58M	Hold	180,000	–	–	0.79%	33
2022 Q1	$4.63M	Buy	+180,000	New	+$5.34M	0.73%	38

Other funds holding VIR

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Clark Estates Inc's VIR Position: Q1 2023 in Review

Clark Estates Inc sold out of Vir Biotechnology (VIR) in Q1 2023, closing a stake of 180,000 shares — an estimated $4.56M sold.

Clark Estates Inc first reported a position in VIR in Q1 2022 and held it in 4 quarters. The position peaked at $4.63M in Q1 2022. 232 funds tracked by Wall St. Rank hold VIR as of Q1 2023.

Clark Estates Inc reported no remaining Vir Biotechnology position as of Q1 2023 after selling out during the quarter.
Clark Estates Inc sold 180,000 Vir Biotechnology shares in Q1 2023, an estimated $4.56M.
Clark Estates Inc first reported a position in Vir Biotechnology in Q1 2022 and held it in 4 quarters.
Clark Estates Inc's Vir Biotechnology position peaked at $4.63M in Q1 2022.
232 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2023.

Based on Clark Estates Inc's 13F filing for Q1 2023, filed 12 May 2023.